Survival rate and death risk for associated pulmonary arterial hypertension: A retrospective population-based study

IF 1.9 Q2 MEDICINE, GENERAL & INTERNAL
Sujin Kim, Shin Yi Jang, Soo Yeon Lee, S. Seo, S. Yi, C. Lee, Eun Jeong Cho, Kyeongsug Kim
{"title":"Survival rate and death risk for associated pulmonary arterial hypertension: A retrospective population-based study","authors":"Sujin Kim, Shin Yi Jang, Soo Yeon Lee, S. Seo, S. Yi, C. Lee, Eun Jeong Cho, Kyeongsug Kim","doi":"10.23838/pfm.2023.00142","DOIUrl":null,"url":null,"abstract":"Purpose: This study aimed to assess the survival rate (SR) and death risk for associated pulmonary arterial hypertension (aPAH; 10th revision of the International Statistical Classification of Diseases [ICD-10], I27.2) in Koreans.Methods: The data were collected from the Korean National Health Insurance Service from 2006 through 2017 (n= 15,448). We analyzed the SR using the Kaplan-Meier method and carried out Cox proportional hazards analyses.Results: Patients’ mean age upon aPAH diagnosis was 60.1±24.0 years, and 60.7% of the patients were female. The 10-year SR of aPAH was 46.3% (95% confidence interval, 45.0 to 47.6). The factors associated with an increase in the adjusted death risk included age of 0 to 9 years, advancing age, male sex, lower income level, and comorbidities including diabetes mellitus, myocardial infarction, heart failure, hemorrhagic stroke, chronic kidney disease, malignant neoplasm, hereditary hemorrhagic telangiectasia, and systemic lupus erythematosus.Conclusion: The 10-year SR of aPAH was over 46%. The risk of death from aPAH was significantly higher with advancing age, sex, lower income level, and comorbidities.","PeriodicalId":42462,"journal":{"name":"Precision and Future Medicine","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision and Future Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23838/pfm.2023.00142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study aimed to assess the survival rate (SR) and death risk for associated pulmonary arterial hypertension (aPAH; 10th revision of the International Statistical Classification of Diseases [ICD-10], I27.2) in Koreans.Methods: The data were collected from the Korean National Health Insurance Service from 2006 through 2017 (n= 15,448). We analyzed the SR using the Kaplan-Meier method and carried out Cox proportional hazards analyses.Results: Patients’ mean age upon aPAH diagnosis was 60.1±24.0 years, and 60.7% of the patients were female. The 10-year SR of aPAH was 46.3% (95% confidence interval, 45.0 to 47.6). The factors associated with an increase in the adjusted death risk included age of 0 to 9 years, advancing age, male sex, lower income level, and comorbidities including diabetes mellitus, myocardial infarction, heart failure, hemorrhagic stroke, chronic kidney disease, malignant neoplasm, hereditary hemorrhagic telangiectasia, and systemic lupus erythematosus.Conclusion: The 10-year SR of aPAH was over 46%. The risk of death from aPAH was significantly higher with advancing age, sex, lower income level, and comorbidities.
伴发肺动脉高压的存活率和死亡风险:基于人群的回顾性研究
目的:本研究旨在评估韩国人伴发肺动脉高压(aPAH;国际疾病统计分类[ICD-10]第10次修订版,I27.2)的存活率(SR)和死亡风险:数据收集自2006年至2017年的韩国国民健康保险服务机构(n= 15448)。我们使用 Kaplan-Meier 法分析了 SR,并进行了 Cox 比例危险度分析:结果:确诊为高血压的患者平均年龄为(60.1±24.0)岁,60.7%的患者为女性。10 年的 aPAH SR 为 46.3%(95% 置信区间为 45.0 至 47.6)。与调整后死亡风险增加相关的因素包括年龄在0至9岁之间、年龄增大、男性、收入水平较低以及合并症,包括糖尿病、心肌梗死、心力衰竭、出血性中风、慢性肾病、恶性肿瘤、遗传性出血性毛细血管扩张症和系统性红斑狼疮:结论:高血压性心脏病的 10 年死亡率超过 46%。结论:高血压肾病的 10 年死亡率超过 46%,年龄越大、性别越高、收入越低、合并症越多,死于高血压肾病的风险就越高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Precision and Future Medicine
Precision and Future Medicine MEDICINE, GENERAL & INTERNAL-
自引率
0.00%
发文量
15
审稿时长
10 weeks
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信